Advanced Technology
PIEZO-ICSI (Piezoelectric Intracytoplasmic Sperm Injection)
Fertility North is one of only two clinics in Western Australia offering PIEZO‑ICSI as part of fertility treatment. The use of PIEZO‑ICSI is currently being evaluated as part of a clinical trial, commenced in 2025, and remains available only to carefully selected patients who meet specific clinical criteria.

What is PIEZO-ICSI?
Often described as a ‘gentler’ approach to traditional ICSI, PIEZO‑ICSI is a technique in which a single sperm is injected into an egg using a high-speed vibration mechanism. This allows the embryologist to penetrate the egg with reduced mechanical force.
How is it different to traditional ICSI?
Intracytoplasmic Sperm Injection (ICSI), used in human fertility treatment since 1992, involves injecting a single sperm directly into the egg using a fine, sharp glass needle that punctures the egg membrane.
In contrast, PIEZO‑ICSI uses a blunt needle in combination with rapid, controlled vibration to enter the egg, rather than piercing it with force. This approach is designed to minimise potential damage to the egg during the injection process.
Who may be considered for PIEZO-ICSI?
Participation in the PIEZO‑ICSI clinical trial is limited to patients who meet specific eligibility criteria, which will be assessed by your doctor. In some cases, PIEZO‑ICSI may be considered where standard ICSI has not achieved optimal outcomes. This may include patients with:
- Previously low fertilisation rates following ICSI
- Higher rates of egg degeneration in prior ICSI cycles
- Poor embryo development
- Increased maternal age, where egg membranes may be more fragile
These factors are provided as a guide only. Your doctor will determine whether PIEZO‑ICSI is appropriate based on your individual clinical circumstances.
Please note that some patients may not be eligible for participation in the study, including those undergoing treatment involving surgically retrieved sperm or donor eggs.
What are the potential advantages?
Some potential advantages of PIEZO‑ICSI may include:
- Less stress on the egg: The gentler technique may reduce damage to the egg membrane, which could help support fertilisation
- May improve outcomes in some patients: In certain cases, particularly where previous ICSI results have been suboptimal
However, it is important to note that PIEZO‑ICSI is currently being offered within a clinical trial setting, and there is no guarantee that it will result in improved fertilisation, embryo development, or pregnancy outcomes.
What are the potential risks of PIEZO?
As PIEZO‑ICSI is new to Australia, the device and procedure are currently not TGA‑approved and are being used within a clinical trial setting. Potential considerations include:
- Outcomes may be similar to, or lower than, those achieved with standard ICSI
- Long‑term data on safety and effectiveness is limited
- As with all assisted reproductive treatments, success cannot be guaranteed
While no significant adverse effects have been reported in studies to date, further research is required to fully understand the safety and effectiveness of this technique.








